Menu

Author Archives: Equity Right

  • Home>
  • Archives for Equity Right
India’s year-end IPO blitz: risks, rewards and what to watchIndia’s year-end IPO blitz: risks, rewards and what to watch
IPO research, Market News - June 21, 2025

Icon Facilitators IPO Launches June 24 with Price Band of ₹85–91

Icon Facilitators IPO Launches June 24 with Price Band of ₹85–91

Through its SME public offering, Icon Facilitators seeks to secure ₹19.11 crore in capital, with a primary focus on strengthening its working capital base and advancing long-term business growth plans.

Icon Facilitators IPO Set to Open on June 24

Icon Facilitators Ltd., a leading name in technical facilities management, is preparing to make its debut on the capital markets with an upcoming SME initial public offering (IPO). The company has officially announced a price range of ₹85 to ₹91 per equity share for the IPO, which is slated to open for public subscription on June 24, 2025. The offering will close just two days later on June 26, 2025, offering investors a brief but critical window to participate.

The IPO will be listed on the BSE SME platform, marking Icon Facilitators’ entry into the public domain and aiming to bolster its operational and financial capabilities through the funds raised.

Key Details of the IPO

As part of its forthcoming IPO, Icon Facilitators intends to generate ₹19.11 crore by issuing 21 lakh fresh equity shares to the public. The IPO opens for anchor investor bidding a day earlier, on June 23, 2025, reflecting growing interest from institutional players in small and mid-sized enterprises.

According to the company’s red herring prospectus (RHP), the bulk of the proceeds—approximately ₹16 crore—will be channeled towards working capital requirements, a move intended to support day-to-day operational liquidity. The remainder will be earmarked for general corporate purposes, such as business expansion, technology upgrades, and administrative needs.

Business Overview: Technical Facilities Expertise

Icon Facilitators is a specialized service provider in the domain of technical facilities management, delivering a comprehensive suite of services across various verticals. Its core competencies include:

• Electrical infrastructure solutions
• Captive power system management
• Water treatment services
• Building automation and management
• Fire and safety system maintenance
• Supervision and servicing of elevator and moving staircase infrastructure

This wide-ranging portfolio enables the company to cater to both industrial and commercial clients seeking turnkey solutions for complex infrastructure and utilities management.

Human Capital and Technical Strength

As of March 31, 2025, Icon Facilitators employed a workforce of over 2,000 individuals, many of whom possess specialized technical knowledge and hands-on experience in diverse areas of the facilities management sector. The company places significant emphasis on domain expertise, which has contributed to its ability to deliver high-quality, reliable, and efficient services across its client base.

Financial Performance Snapshot

Icon Facilitators has demonstrated robust financial growth in recent years, reflecting operational strength and increasing market demand. In FY25, the company posted a revenue from operations of ₹58.06 crore, a healthy increase from ₹49.84 crore in FY24. Profit after tax (PAT) saw a notable jump as well, rising from ₹1.76 crore in FY24 to ₹4.47 crore in FY25—a clear indicator of improved efficiency and profitability.

The financial momentum places the company on strong footing as it steps into the public market, with investors likely to take note of the upward earnings trajectory.

Management of the Issue

While no specific analysts or financial firms are highlighted, the IPO process is being professionally managed. A dedicated book-running lead manager is overseeing the issue’s execution, ensuring regulatory compliance and a smooth subscription process. The appointed registrar is handling investor applications, allotments, and post-issue formalities on behalf of the company.

Strategic Objectives Behind the IPO

The upcoming IPO is a strategic move by Icon Facilitators to secure long-term growth capital. By directing a major portion of the funds towards working capital, the company aims to streamline operations, enhance service delivery, and expand its client base. The remainder of the proceeds will empower the firm to maintain financial agility and invest in future growth areas as market conditions evolve.

This step also reflects the company’s commitment to greater transparency, governance, and value creation as it transitions into a listed entity.

Final Thoughts

Icon Facilitators Ltd. is entering a new growth phase with its IPO opening on June 24, offering shares in the ₹85–91 price band. With a focus on raising over ₹19 crore, the company aims to reinforce its working capital base while laying the groundwork for future expansion.

Its strong financial performance, diversified service offerings, and technically skilled workforce create a solid foundation for investor confidence. For market participants seeking exposure to the facilities management sector within the SME space, this IPO could represent a promising opportunity.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Natco Pharma Shares Tumble After USFDA Concerns

, , , , , , , 0 Comment
Read More
Strategic Consolidation: Emcure to Fully Take Over Zuventus Healthcare
business update, Equities, Market News - June 21, 2025

Natco Pharma Shares Tumble After USFDA Concerns

Natco Pharma Shares Tumble After USFDA Concerns

The USFDA concludes inspection at Natco Pharma’s Kothur plant with seven observations, triggering a stock sell-off and raising regulatory compliance concerns among investors.

Summary:
Natco Pharma shares declined sharply after the USFDA issued seven observations following an inspection at its Kothur manufacturing facility near Hyderabad. The development raises short-term compliance concerns and puts regulatory scrutiny back in focus for the Indian pharmaceutical company. The market response reflects investor caution, although management has committed to addressing all issues raised.

USFDA Inspection Triggers Investor Anxiety at Natco Pharma
Hyderabad, India — This week, Natco Pharma Ltd’s shares faced downward pressure following the company’s announcement that the United States Food and Drug Administration (USFDA) had completed an inspection of its Kothur manufacturing facility near Hyderabad, resulting in seven observations. The news rattled investor sentiment, leading to a drop of nearly 5% in intraday trade, as regulatory compliance once again took centre stage in India’s closely watched pharmaceutical sector.
The inspection, conducted as part of routine regulatory oversight by the USFDA, was carried out at the Formulations Division in Kothur, Telangana, between June 10 and June 17, 2025. While no serious violations or import alerts have been reported yet, the issuance of seven Form 483 observations has raised concerns about the company’s quality control, documentation practices, and adherence to global manufacturing standards.

What is a Form 483?
A Form 483 is provided by the US FDA to point out conditions that could potentially be violations of the Food, Drug, and Cosmetic Act. These are typically observations made during on-site inspections and are intended to notify the company of potential issues. While not indicative of an immediate enforcement action, these observations can lead to further scrutiny, warning letters, or even delays in product approvals if not addressed satisfactorily.
In Natco’s case, while the company has not disclosed the specifics of the seven observations, it has acknowledged its receipt and stated its intent to submit a detailed response to the USFDA within the stipulated time frame.

Company Statement: Prompt Action Initiated
In a regulatory filing with the stock exchanges, Natco Pharma said:
“The USFDA has concluded an inspection at our Kothur unit with seven observations. We are preparing our comprehensive response and are committed to resolving all issues in a timely and compliant manner.”
Company insiders suggest that the observations pertain primarily to procedural deviations, documentation gaps, and areas of improvement in manufacturing processes rather than critical data integrity issues or safety violations. However, the nature and number of the observations are enough to trigger investor caution.

Stock Market Reaction
The market did not take the news lightly. Natco Pharma’s stock opened lower and slid further during intraday trading on the NSE, closing down by 4.8% at ₹775.30, compared to the previous close of ₹814.15. Trading volumes were unusually high, signalling panic selling among retail and institutional investors.
Brokerages reacted cautiously:
Motilal Oswal termed the development “watchful” and advised clients to await clarity on the nature of observations before making further investment decisions.
ICICI Securities noted that although Natco has a history of overcoming previous regulatory challenges, the presence of multiple observations raises the likelihood of delays in ANDA approvals, which could impact production schedules.

Impact on Business Operations and Approvals
Natco’s Kothur facility is a critical unit in the company’s production chain, supplying oral solid dosage formulations for both domestic and international markets. Importantly, this unit also handles several Abbreviated New Drug Applications (ANDAs) filed with the USFDA.
Analysts fear that unless the observations are resolved promptly:
Pending approvals may get delayed, impacting revenue inflows from the lucrative U.S. market.
The company may face greater scrutiny in future inspections, leading to operational disruptions.
Confidence from global partners and contract manufacturing clients may temporarily waver.
It is worth noting that the U.S. market accounts for nearly 35% of Natco Pharma’s revenues, making any regulatory hurdle a significant issue for both earnings and sentiment.

Regulatory Track Record: A Mixed Bag
This isn’t the first time that Natco has encountered regulatory scrutiny. While the company has successfully cleared inspections in the past, some of its facilities—including those in Visakhapatnam and Chennai—have received observations previously, though none have escalated to warning letters or import bans.
Industry observers argue that the situation remains manageable but should be monitored closely over the coming weeks, especially for any escalation in USFDA actions.

Analyst Take: Long-Term Fundamentals Intact
Despite the current setback, analysts point out that Natco Pharma remains a fundamentally strong player in the oncology, respiratory, and chronic therapeutics segments, with a robust pipeline and growing international footprint.
The company’s partnerships with global players, recent launches of complex generics, and strategic focus on high-entry-barrier products position it well for medium- to long-term growth.
Investors are advised to:
Track updates from the company on progress in resolution.
Watch for changes in USFDA’s tone in subsequent inspections or correspondence.
Focus on upcoming quarterly earnings to evaluate any operational or margin impact due to regulatory challenges.

Conclusion
The seven observations from the USFDA regarding Natco Pharma’s Kothur facility have once again highlighted the regulatory risks that have long been a concern in India’s pharmaceutical industry. While the impact appears manageable for now, the development underscores the importance of continuous compliance and operational vigilance in maintaining global credibility.
As the company works toward addressing the USFDA’s feedback, all eyes will be on its remediation plan and response timelines. For investors, the near-term may bring volatility, but the long-term value could remain intact if Natco navigates this phase effectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Waaree Energies Surges Over 11% on FTSE Index Inclusion Buzz

, , , , , , , , , , 0 Comment
Read More
Waaree Energies Surges Over 11% on FTSE Index Inclusion Buzz
Equities, Market News - June 21, 2025

Waaree Energies Surges Over 11% on FTSE Index Inclusion Buzz

Waaree Energies Surges Over 11% on FTSE Index Inclusion Buzz

Waaree Energies accelerates as news of FTSE index addition fuels investor enthusiasm, paving the way for heightened international visibility and capital influx.

Waaree Energies Climbs Sharply Following Buzz Around FTSE Index Addition and Rising Investment Interest

Shares of Waaree Energies rallied more than 11% on June 20 after confirmation of its upcoming inclusion in the FTSE Global Index sparked robust investor interest. The stock soared to an intraday high of ₹2,975, driven by expectations of passive fund inflows tied to the index adjustment.

The momentum reflected investors’ anticipation of increased liquidity and greater global visibility for the solar module manufacturer. This move is expected to mark a pivotal moment in Waaree’s ongoing growth narrative, particularly as it continues to expand internationally.

Passive Inflows Expected to Boost Waaree by $49 Million

The FTSE Global Index, maintained by the London-based Financial Times Stock Exchange, is undergoing its latest portfolio reshuffle. The rebalancing, effective from June 23, is expected to usher in considerable passive investments from institutional funds tracking the index.

Waaree Energies is estimated to benefit from approximately $49 million in such inflows. This projected investment is expected to bolster not just the company’s stock price in the short term, but also its stature among global market participants.

Several other Indian firms are also slated to gain from the FTSE reshuffle. Among the notable beneficiaries are Vishal Mega Mart, projected to receive around $115 million, Hyundai Motor India with an estimated $56 million, Swiggy at $32 million, and NTPC Green Energy expecting approximately $22 million in inflows. Moreover, companies like Afcons Infrastructure, Sai Life Sciences, OneSource Specialty Pharma, and Inventurus Knowledge are expected to draw increased attention as contenders for FTSE index addition.

Strategic Growth in the U.S. Market Amplifies Momentum

While the FTSE development lit the spark, Waaree’s recent gains also stem from its impressive strides in the U.S. renewable energy sector. The company’s American subsidiary, Waaree Solar Americas, has secured significant supply contracts, including a 586 MW order and another for 599 MW from top-tier independent power producers.

Despite political uncertainties around renewable energy policies in the U.S., including proposals that may reduce incentives for the sector, Waaree’s growth remains strong. The company continues to find traction in the market and is undeterred by potential regulatory headwinds.

To meet growing demand, Waaree is doubling the production capacity at its Brookshire, Texas facility. The expansion is aimed at reaching 3.2 GW by the end of 2025, reinforcing Waaree’s ambition to solidify its place as a key player in the global solar energy space.

Market Overview: Share Price Approaches ₹3,000 Within a Wide Price Band

With the latest rally, Waaree Energies’ share price has come within striking distance of the ₹3,000 mark. While still trading about 22% below its 52-week peak of ₹3,740.75 (recorded in November 2024), the stock has made a sharp recovery from its 52-week low of ₹1,808.65, touched in April 2025.

So far in June, the stock has dipped 2.3%, but prior months painted a more bullish picture—with May seeing a 14.4% gain, April rising by 8.3%, and March climbing 11.4%. These gains followed back-to-back losses of 10% and 16% in February and January, respectively.

From its IPO price of ₹1,503, Waaree Energies has now delivered a staggering 98% return, underlining sustained investor confidence in the company’s execution capabilities and long-term prospects.

Technical Overview: Bullish Setup Signals Further Upside Potential

Technically, the stock appears to be forming an ascending triangle on the daily chart—an indicator often associated with bullish continuation patterns. This suggests that accumulation is ongoing and a potential breakout could be on the horizon.

On June 20, strong buying emerged from support zones, accompanied by higher-than-average trading volumes. The stock has decisively closed above both its 20-day and 50-day exponential moving averages (EMAs), pointing to a strengthening short- to medium-term trend.

The Relative Strength Index (RSI) currently hovers around 62 and is on an upward trajectory, reflecting increasing bullish momentum. Should the stock break past the ₹3,050 resistance level, it could see further upside, potentially targeting the ₹3,300 zone in the coming sessions.

Final Thoughts

Waaree Energies’ over-11% surge on June 20 came as a response to the company’s confirmation for inclusion in the FTSE Global Index—an event expected to draw substantial passive investments. But beyond this catalyst, Waaree’s fundamental strength, strategic expansion in the U.S., and strong technical indicators all contribute to a compelling growth story.

The stock’s rebound from its April low, near-doubling since IPO, and resilience in the face of global policy shifts highlight the market’s faith in its long-term vision. Investors and traders alike will be closely watching for a confirmed breakout in the coming days, which could kickstart the next leg of Waaree’s rally.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

India Suspends Tea Exports to Iran: Market Crisis Looms

, , , , , , , 0 Comment
Read More
BEML Secures $6.23M Export Orders from Russia, Uzbekistan!
Economy, Market News, Markets - June 21, 2025

India Suspends Tea Exports to Iran: Market Crisis Looms

India Suspends Tea Exports to Iran: Market Crisis Looms

India has halted tea exports to Iran in light of escalating tensions between Iran and Israel. This move could threaten the premium orthodox tea trade and access to West Asian markets through the Strait of Hormuz.

Summary:
Due to the escalating conflict between Iran and Israel, India has put a temporary hold on its tea exports to Tehran. The halt, prompted by diplomatic caution and disrupted communication channels, directly affects the shipment of premium orthodox tea valued at ₹100–150 crore. Concerns are mounting over trade routes through the Strait of Hormuz, threatening broader West Asian market access and raising fears of prolonged economic implications for India’s tea industry.

India’s Tea Trade Stalls Amid Israel-Iran Conflict: Strategic and Economic Ramifications
As tensions escalate between Iran and Israel, ripple effects are being felt far beyond the Middle East, with India suspending its tea exports to Iran—a major buyer of premium Indian orthodox tea. The decision, although unofficially termed “temporary,” is deeply rooted in the growing security concerns and communication breakdown triggered by the ongoing conflict.
According to trade sources and industry officials, tea shipments valued between ₹100–150 crore annually—primarily comprising high-quality orthodox tea from Assam and Darjeeling—have now come to a halt. This marks a significant blow to India’s tea exporters, especially at a time when the industry is already grappling with global inflation, shipping disruptions, and rising input costs.

Why Did India Halt Tea Exports to Iran?
The tea export halt comes amidst a diplomatic deadlock and geopolitical volatility stemming from the active Iran-Israel conflict, which has intensified military actions, cyber warfare, and threats to regional shipping routes.
Several Indian tea exporters have reported:
Breakdown in banking and payment communication with Iranian counterparts.
Concerns over logistical risks in West Asia, especially due to threats around the Strait of Hormuz, a vital trade artery for India’s exports.
A general de-risking approach advised by export associations and government advisories amid rising tensions.
A Kolkata-based tea exporter stated, “We’ve had to stop processing orders for Iran because there’s no clarity on payments, and the insurance cost for shipments has spiked. Even letters of credit are now being reviewed more stringently.”

Impact on the Indian Tea Industry
India exports nearly $800–900 million worth of tea annually, with Iran ranking among the top five buyers—particularly for orthodox teas, which fetch higher margins compared to standard CTC (crush-tear-curl) teas.
Key implications of the suspension include:
Revenue Loss: An immediate impact on shipments valued at ₹100–150 crore, mostly for orthodox tea, which is costlier to produce and has fewer buyers globally.
Inventory Pile-Up: Exporters and tea gardens in Assam and Darjeeling fear accumulation of unsold stock, leading to cash flow bottlenecks.
Price Pressure: Domestic tea prices may fall due to oversupply in the absence of Iran-bound exports, hurting tea growers and small producers.
Market Uncertainty: With Russia and the UAE already facing sanctions-related trade scrutiny, Iran’s exit, even temporarily, squeezes options for Indian exporters.
Tea Board officials have expressed concern over these developments and are closely monitoring the situation. While some exporters are exploring alternative markets in Central Asia and Eastern Europe, such transitions take time and do not guarantee the exact pricing or volume.

Strait of Hormuz: A Strategic Choke Point
A significant concern is the Strait of Hormuz, which serves as a passage for about 20% of the world’s oil and a large amount of cargo, including exports from India. Any military escalation that impairs navigation through this strait could:
Disrupt West Asian trade routes
Increase shipping insurance premiums
This leads to delays or cancellations in high-value cargo deliveries
If the conflict expands further, India’s entire export strategy for the West Asia-North Africa (WANA) region may need revision, with wide-ranging effects on agro-products, textiles, and pharmaceuticals in addition to tea.

Industry Reaction & Government Engagement
The Tea Exporters Association of India (TEAI) and other trade bodies are urging the Indian government to intervene diplomatically and help set up alternative payment mechanisms or consider re-routing shipments through neutral ports.
A senior member of the Indian Tea Association (ITA) said, “The government should assess possibilities of barter trade or localized payment arrangements like rupee-rial trade, as used earlier, to mitigate the crisis. Iran remains a vital market for orthodox tea.”
Meanwhile, small tea growers in North Bengal and Assam have started protesting delayed payments from private buyers and auction houses, citing the Iran disruption as one of the root causes.

Geopolitical Tensions and Economic Fallout
India has so far maintained a neutral stance in the Israel-Iran conflict, calling for de-escalation and peaceful resolution through dialogue. However, economic interests like energy security and trade stability are deeply intertwined with regional peace.
Experts argue that:
The instability of the Middle East could impact India’s oil import bill and foreign exchange reserves.
Strategic sectors like tea, spices, and agro-exports could suffer due to shipping insurance surges and war risk premiums.
If the conflict persists or escalates, there may be long-term trade realignments, affecting India’s traditional trade partners and pushing it to diversify export geographies.

Looking Ahead: Contingency and Adaptation
With no immediate resolution in sight, Indian tea exporters are now being advised to:
Pause new orders to Iran until clarity on trade channels is restored.
Diversify into Africa, Central Asia, and Southeast Asia to reduce dependency on West Asia.
Enhance domestic marketing of orthodox tea to absorb excess stock.
Government agencies may also step in with export subsidies or support schemes to assist affected stakeholders in the tea supply chain.

Conclusion
The sudden halt in India’s tea exports to Iran, prompted by the ongoing Israel-Iran conflict, underscores how deeply global geopolitical tensions can impact localized industries and small businesses. As diplomacy races against time and military escalations, India’s tea sector stands at a critical crossroads—one that will test its resilience, adaptability, and strategic foresight in global trade.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

BEL Bags Fresh Defence Orders Worth ₹585 Crore, Expands Strategic Focus

, , , , , , , , , , 0 Comment
Read More
BEL Bags Fresh Defence Orders Worth ₹585 Crore, Expands Strategic Focus
Equities, Market News - June 21, 2025

BEL Bags Fresh Defence Orders Worth ₹585 Crore, Expands Strategic Focus

BEL Bags Fresh Defence Orders Worth ₹585 Crore, Expands Strategic Focus

Bharat Electronics clinchesb major defence deals spanning missile technology, electronic jammers, and surveillance solutions, amplifying its commitment to the Make in India vision.

BEL Clinches Fresh Defence Contracts Valued at ₹585 Crore

Bharat Electronics Limited (BEL), a leading Navratna defence enterprise, has revealed securing new military contracts totaling ₹585 crore since June 5, 2025. This recent order inflow strengthens BEL’s ongoing momentum in securing advanced defence technology contracts and further fortifies its role in India’s defence preparedness.
The company disclosed these developments in its latest regulatory filing with the National Stock Exchange (NSE), underscoring its proactive approach in expanding its defence portfolio. These new orders will help BEL maintain its leadership position in developing state-of-the-art defence technologies aligned with national security objectives.

Key Orders Include Missile Sighting Systems and Communication Gear

The recently acquired orders encompass a diverse array of cutting-edge military technologies and systems. Among the critical supplies are fire control systems and missile sighting equipment, vital for enhancing the accuracy and effectiveness of India’s missile forces. Additionally, BEL will be providing sophisticated communication gear, electronic jammers, essential spares, and technical services as part of these orders.

These technologies play a crucial role in strengthening the operational efficiency of India’s armed forces, particularly in today’s rapidly evolving battlefield environments where digital warfare and precision targeting are increasingly critical.

BEL: A Defence Giant with Expanding Capabilities

Bharat Electronics Limited operates under the Ministry of Defence and holds the esteemed Navratna PSU status, recognizing its importance in India’s defence manufacturing ecosystem. Through consistent growth and innovation, BEL has transformed into a versatile technology-driven entity, offering a broad spectrum of advanced solutions across various defence sectors.

The company’s expertise covers an extensive range of systems including advanced Radars, Weapon and Fire Control Systems, C4I (Command, Control, Communications, Computers, and Intelligence) setups, Electronic Warfare and Avionics, naval systems, Electro-Optics, Tank Upgrades, Satellite Communication (Satcom) systems, and more. Additionally, BEL also delivers technological solutions for both strategic and civilian markets.

Expanding Horizons Beyond Defence

While defence remains BEL’s core strength, the company has been actively expanding into non-defence sectors in recent years. This diversification includes forays into Homeland Security, Cyber Security, Railways, Metro Systems, Civil Aviation, Medical Electronics, Space Electronics, and Anti-Drone Systems.

BEL’s ventures into these segments demonstrate its ability to innovate and provide cutting-edge technological solutions beyond traditional defence applications. Leveraging opportunities in evolving sectors, BEL is carving a path toward long-term expansion and a stronger footprint within India’s advancing tech ecosystem.

Breakthrough in Drone Detection Systems

A significant milestone in BEL’s recent achievements is its partnership with the Indian Army Air Defence to deliver the Integrated Drone Detection and Interdiction System (IDDIS). This system, developed in collaboration with the Defence Research and Development Organisation (DRDO), exemplifies BEL’s innovation capabilities and strategic alignment with India’s security needs.

The IDDIS is engineered to detect, track, and neutralize rogue drones, providing a vital layer of defence against increasingly sophisticated aerial threats. As drone warfare becomes a growing concern globally, India’s proactive steps in deploying such systems position the country’s defence forces at the forefront of counter-drone capabilities.

This initiative also falls in line with the Government of India’s Make in India campaign, promoting indigenous defence manufacturing and reducing dependency on imported security technologies.

Commitment to Self-Reliance and National Security

BEL’s recent contract wins reflect more than just financial success—they highlight the company’s critical role in contributing to India’s defence self-reliance. By persistently advancing its technological capabilities, BEL strengthens its dedication to enhancing India’s defense ecosystem and safeguarding national interests.

With the integration of advanced systems such as IDDIS, alongside missile sighting solutions and cutting-edge communication equipment, BEL is effectively bridging the gap between evolving security threats and India’s preparedness to address them.

Final Thoughts

Bharat Electronics Limited continues to build upon its legacy as one of India’s foremost defence technology providers. The ₹585 crore worth of fresh orders, comprising advanced missile systems, jammers, and drone detection technologies, underscores the company’s pivotal role in strengthening the country’s security framework.

By simultaneously expanding into non-defence sectors, BEL showcases adaptability and forward-thinking leadership. As the demand for indigenous defence systems accelerates under the Make in India initiative, BEL is strategically positioned to lead India’s technological self-reliance both in defence and beyond.

The ongoing collaboration with DRDO and other defence entities further enhances BEL’s stature as a trusted partner in India’s defence modernization journey, paving the way for continued innovation, growth, and national pride.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Kretto Syscon Soars: Bonus & 100% Dividend Buzz!

, , , , , , , 0 Comment
Read More
Bhatia Communications Declares Final Dividend, Sets Record Date for FY25
Equities, Market News - June 21, 2025

Kretto Syscon Soars: Bonus & 100% Dividend Buzz!

Kretto Syscon Soars: Bonus & 100% Dividend Buzz!

Kretto Syscon Ltd—trading under ₹5—soars to the upper circuit as investors cheer possible bonus share issuance and 100% dividend recommendation in an upcoming board meeting.

Summary:
Kretto Syscon Limited, a penny stock trading below ₹5, surged to its upper circuit after the company notified the stock exchanges about a board meeting scheduled for July 15, 2025. The meeting will consider issuing bonus shares or recommending a 100% final dividend for FY2024–25. The stock, already considered a multi-bagger, has gained investor attention for its consistent performance and shareholder-friendly actions.

Kretto Syscon’s Rise: Penny Stock Powers to Upper Circuit on Bonus & Dividend Buzz
In a strong display of investor optimism, Kretto Syscon Limited, a penny stock priced below ₹5, hit its upper circuit on Friday following a regulatory filing that has stirred bullish sentiment. The trigger: an upcoming Board of Directors’ meeting scheduled for July 15, 2025, to consider two key shareholder-friendly proposals—issuance of bonus shares and a 100% final dividend for the financial year ended March 31, 2025.
This announcement has sparked widespread interest among retail investors and small-cap trackers, with many eyeing the stock for its multi-bagger potential. Despite being a microcap company, Kretto Syscon’s recent performance and corporate actions have catapulted it into the spotlight as a potential wealth creator in the penny stock segment.

Regulatory Filing Sparks Rally
As per the stock exchange filing submitted to both BSE and NSE, the company stated:
“A meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 15, 2025, to consider and approve, inter alia:
The recommendation of a Final Dividend of up to Re 1 per equity share (100%) for the financial year ended March 31, 2025, and/or
The issuance of Bonus Shares is subject to requisite approvals.”
The board will also deliberate on other corporate matters, which could include growth strategies, business expansion plans, or operational updates.
This development led to a frenzied buying spree, with the stock quickly hitting its 5% upper circuit limit, halting further trades due to a surge in demand.

Why the Market Is Excited
For a stock priced under ₹5, to consider either a 100% dividend or bonus shares is relatively uncommon. Typically, penny stocks lack the financial muscle to reward shareholders in this fashion. That’s precisely why Kretto Syscon’s announcement has created a buzz:
High Dividend Yield: At Re 1 per share, the implied dividend yield exceeds 20% based on current market prices—a rare feat in microcap and penny stock territory.
Bonus Share Speculation: Issuing bonus shares often signals management confidence in future profitability and growth. It improves stock liquidity and enhances retail participation.
Sign of Strength: For a small company to consider such capital allocation shows underlying cash flow strength and profitability, especially if both actions are considered simultaneously.
Investors are now anticipating a sharp rerating of the stock should either or both proposals be approved and executed.

Stock Performance and Multibagger Credentials
Over the last 12 months, Kretto Syscon has delivered stellar returns, rising from mere paisa-level lows to its current price of just under ₹5. This represents a return of over 300% in a single year, effectively making it a multi-bagger in penny stock terms.
Several factors have contributed to this meteoric rise:
Improving Financials: Quarterly earnings have shown modest yet consistent improvement in revenue and profitability metrics.
Sectoral Tailwinds: The company, operating in the IT-enabled services (ITES) and consultancy space, has benefited from increased digitization and SME-level automation.
Retail Buzz: Social media chatter, small-cap forums, and YouTube influencers have played a significant role in generating investor interest.
Despite its run-up, the stock remains in penny territory—thereby attracting risk-tolerant investors looking for asymmetric reward opportunities.

Risks and Caution Flags
While excitement is warranted, caution is equally essential. Penny stocks often carry higher-than-average risks due to:
Low Liquidity: A sudden exit may be difficult for large investors.
Price Volatility: A small trigger, such as board decision deferral or non-approval from exchanges, can crash the stock quickly.
Lack of Institutional Coverage: With minimal analyst attention, fundamental clarity is often scarce.
Investors should also be wary of stock operator manipulation, which is not uncommon in thinly traded microcaps.

What’s Next? July 15 Board Meeting Holds the Key
All eyes are now set on the July 15 board meeting, where a final decision will be taken regarding:
Bonus Share Ratio – If bonus shares are approved, the ratio (e.g., 1:1 or 2:1) will significantly influence investor sentiment.
Final Dividend Approval – Re 1 per share could set a strong precedent for future payouts.
Strategic Announcements – The board may also consider future capex, expansion into new geographies, or changes in management structure.
If either action is approved, Kretto Syscon may further rerate, pushing it toward becoming a serious microcap contender rather than just a speculative penny stock.

Conclusion
Kretto Syscon’s story encapsulates the dual nature of investing in India’s microcap universe: high risk, high reward. While the upcoming board decision could catapult the stock to new heights, prudent investors must weigh the fundamentals and volatility risks before making a move.
Nevertheless, the company’s intent to reward shareholders through bonuses or dividends—a rare move in the penny stock space—reflects growing confidence and financial stability. If backed by strong Q1 FY26 earnings and sustained momentum, Kretto Syscon might just become a rare gem in India’s crowded penny stock ecosystem.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Aakaar Medical IPO Sees 37% Day 1 Subscription Backed by Strong NII Demand

, , , , , , , , , , 0 Comment
Read More
Indian Startups Accelerate IPO Parade as Market Matures in 2025
IPO research, Market News - June 21, 2025

Aakaar Medical IPO Sees 37% Day 1 Subscription Backed by Strong NII Demand

Aakaar Medical IPO Sees 37% Day 1 Subscription Backed by Strong NII Demand

Aakaar Medical Technologies’ ₹27 crore IPO garners investor traction on opening day, led by non-institutional and QIB participation; listing set for June 27.

Aakaar Medical Technologies Makes Modest Debut in IPO Arena

On June 20, Aakaar Medical Technologies, headquartered in Mumbai, opened its SME IPO with the objective of securing ₹27 crore via the issuance of entirely new equity shares. On the very first day of the offering, the IPO saw a subscription of 37%, with most of the demand coming from non-institutional investors (NIIs) and qualified institutional buyers (QIBs).

Despite being early in the subscription window, this level of response suggests growing investor interest in emerging healthcare equipment players, particularly those in the B2B space like Aakaar.

IPO Details: Price Band, Lot Size, and Minimum Investment

The IPO is a book-built issue with a price range set between ₹68 and ₹72 per share. The minimum lot size is 1,600 shares, translating into a base investment requirement of ₹1,08,800. Investors can scale up to a maximum of ₹1,15,200 per application, depending on the upper end of the price band.

This offering is fully composed of a fresh equity issue, with no existing shareholders offloading their stakes through an offer-for-sale (OFS). The capital raised will go toward business expansion and operational growth.

Segment-Wise Subscription Breakdown: NII and QIB Segments Lead

On Day 1, the IPO recorded an overall subscription of 37%. The non-institutional investor category led the charge with a 59% subscription rate, while qualified institutional buyers followed with a 33% subscription.

Retail investors, typically a strong base for SME IPOs, contributed a more cautious 30% to the total subscriptions. The early trend suggests that larger investors are more confident in Aakaar’s business model and long-term potential.

Share Allotment, Listing Date, and Exchange Details

The IPO window remains open for bidding until June 24. Share allotment is expected to be finalized by June 25, and successful applicants can anticipate share credits shortly thereafter.

Aakaar Medical Technologies’ shares are scheduled to debut on the NSE Emerge platform on June 27. NSE Emerge is known for offering a gateway for SMEs to access capital markets and improve business visibility.

Company Overview: What Does Aakaar Medical Technologies Do?

Aakaar Medical Technologies is involved in the design and manufacturing of medical-grade devices and products. The firm primarily functions within the business-to-business (B2B) space, delivering its medical equipment to healthcare providers such as hospitals, clinics, and other medical facilities.

Headquartered in Mumbai, Aakaar focuses on innovation-driven products tailored for diagnostic and therapeutic applications. Its strength lies in product development and scalable manufacturing—both key drivers in India’s expanding healthcare infrastructure.

Market Potential and Investor Sentiment

India’s medical device sector is undergoing rapid transformation, spurred by the government’s emphasis on domestic manufacturing and healthcare access. In this evolving landscape, companies like Aakaar are strategically positioned to benefit from rising demand for affordable and high-quality equipment.

The IPO’s initial response, particularly from NIIs and institutional buyers, reflects a belief in Aakaar’s ability to capitalize on sectoral growth. Though retail investors showed relatively limited enthusiasm on Day 1, subscription trends could strengthen in the following days as broader awareness builds.

Why This IPO Matters for Investors

For investors looking to tap into India’s growing healthcare manufacturing sector, Aakaar Medical Technologies offers a fresh opportunity. The firm’s SME IPO format comes with its own set of risks and volatility, but also the potential for high returns if the business scales effectively post-listing.

Its choice to list on NSE Emerge allows the company to maintain compliance standards while gaining exposure to a broader investor base. The absence of an OFS component also sends a positive signal, suggesting promoters are focused on growth rather than short-term exits.

Final Thoughts

Aakaar Medical Technologies has made a moderately strong entrance into the capital market with a 37% IPO subscription on Day 1. Interest was primarily fueled by non-institutional and institutional investors, indicating a degree of trust in the company’s fundamentals and industry prospects.

As the IPO approaches its closing date on June 24 and prepares for listing on June 27, investor focus is expected to pivot toward share allotment results and the company’s performance after it hits the market. As the Indian medical devices sector expands, Aakaar’s journey from an SME player to a publicly listed entity will be closely watched by market participants.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Dilip Buildcon Shares Surge After Bagging ₹1,341 Crore Konkan Railway Project

, , , , , , , 0 Comment
Read More
Dilip Buildcon Shares Surge After Bagging ₹1,341 Crore Konkan Railway Project
Market News - June 21, 2025

Dilip Buildcon Shares Surge After Bagging ₹1,341 Crore Konkan Railway Project

Dilip Buildcon Shares Surge After Bagging ₹1,341 Crore Konkan Railway Project

Dilip Buildcon, one of India’s leading infrastructure development companies, recently secured a major contract worth ₹1,341 crore from Konkan Railway Corporation Limited (KRCL). The project, which focuses on improving connectivity in Kerala’s challenging terrains, has generated renewed investor interest, triggering a notable rise in the company’s share price.

Key Project Details

The contract awarded to Dilip Buildcon involves the construction of twin tunnels, each stretching approximately 8.3 kilometers. In addition to these tunnels, the company will develop a four-lane approach road that will improve transport links between Anakkampoyil, Kalladi, and Meppadi in Kerala. This infrastructure is expected to significantly reduce travel time in the region and provide a much-needed transportation upgrade.

The project comes with a strict execution timeline of 48 months. Successfully handling such a complex project will further strengthen Dilip Buildcon’s reputation as a dependable player in India’s infrastructure sector, particularly in projects that involve challenging geographies like hilly regions.

 

Strong Stock Performance Following the Order Win

The market responded immediately to this development. On June 20, 2025, Dilip Buildcon’s shares saw a healthy intraday jump of nearly 4%, briefly touching ₹506.80 on the Bombay Stock Exchange. By the end of the session, the stock closed near ₹492.70, still holding on to gains of around 1.1% for the day.

This rise slightly outperformed the broader Nifty 50 index, which posted a gain of approximately 0.95% on the same day. The stock’s movement was supported by increased investor participation, as reflected in the significant rise in trading volumes.

Financial Snapshot: Q4 FY25

Despite the positive momentum from the new project, Dilip Buildcon’s financial results for the March 2025 quarter presented a mixed picture. The company reported a substantial increase in net profit, which climbed to ₹170.83 crore compared to ₹5.34 crore in the same quarter of the previous year. This sharp jump indicates that the company has been able to improve its operational efficiency and project delivery timelines.

On the revenue side, however, the company recorded a year-on-year decline of nearly 13%, with the total revenue falling to ₹3,096.1 crore. In addition, the company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) dropped significantly, with the EBITDA margin narrowing to around 9% from its earlier levels.

While the revenue and margin pressures are evident, the sharp growth in net profit demonstrates Dilip Buildcon’s ability to manage costs and deliver on its projects efficiently despite sectoral challenges.

Strengthening the Project Pipeline

This latest order will further boost Dilip Buildcon’s already strong order book, giving the company long-term revenue visibility. Over the years, the company has expanded its portfolio across multiple infrastructure segments, including highways, tunnels, mining, and urban development.

Winning this complex tunnel project in Kerala strengthens Dilip Buildcon’s market position, especially in technically demanding assignments that require precision and experienced management. The company’s growing list of projects reflects its competitiveness in securing large contracts in India’s fast-growing infrastructure space.

Investor Sentiment and Growth Outlook

The company’s share price movement following the project announcement shows that investors continue to have confidence in Dilip Buildcon’s execution capabilities. Since the beginning of 2025, the stock has delivered a steady return of around 9.5%, outpacing the performance of the Nifty 50 index, which has risen by approximately 5.2% over the same period.

However, infrastructure projects located in hilly areas come with execution risks such as weather-related delays, challenging logistics, and the need for specialized machinery. Timely execution will be essential to avoid penalties and cost overruns.

Looking forward, Dilip Buildcon is expected to benefit from the Indian government’s continued emphasis on infrastructure development, particularly in roads, railways, and urban transport. As a well-established player with proven project delivery, the company is well-positioned to capitalize on future opportunities in the sector.

Conclusion

Dilip Buildcon’s success in securing the ₹1,341 crore project from Konkan Railway is a major milestone that reinforces its technical expertise and strengthens its project portfolio. The market’s positive response following the announcement highlights investor trust in the company’s ability to manage large, complex assignments.

While there are challenges ahead, including execution risks and pressure on margins, Dilip Buildcon’s expanding order book and solid track record point toward sustainable growth. With disciplined project management and timely delivery, the company appears well-placed to maintain its momentum and continue attracting investor interest.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Aeroflex Industries jumps 29% in three days on Kacholia backing.

, , , , , , , , 0 Comment
Read More
Nila Spaces Jumps 10% as Wellness Housing Project Gets RERA Clearance
Banking, Equities, Market News - June 21, 2025

Aeroflex Industries jumps 29% in three days on Kacholia backing.

Aeroflex Industries jumps 29% in three days on Kacholia backing.

Specializing in stainless-steel flexible hoses, small-cap player Aeroflex Industries has seen its stock price soar by almost 29% over the past three sessions. The surge comes amid strong value buying, increasing investor interest, and the backing of well-known investor Ashish Kacholia, who has steadily increased his stake in the company. The sharp upswing has sparked discussions in market circles regarding the stock’s potential and the company’s growth prospects.

Strong Rally Driven by Heavy Volumes

Aeroflex Industries’ stock rallied approximately 11% on June 20, 2025, closing near ₹216–₹217 per share, its strongest level in nearly four months. This rally is not a one-day phenomenon. In the last three consecutive trading sessions, the stock has surged a remarkable 29%, fueled by unusually heavy trading volumes.

The BSE recorded trading volumes exceeding 87 lakh shares, significantly higher than the company’s two-week average of about 6.97 lakh shares. Such a sharp increase in volume suggests that aggressive buying interest is supporting the current uptrend. Analysts view this surge as a technically driven move, supported by strong market momentum.

Technical Breakout and Bullish Indicators

Technical charts have confirmed a breakout for Aeroflex Industries. The stock has convincingly moved above its key moving averages ranging from the 5-day to the 200-day averages. Additionally, the Relative Strength Index (RSI) has crossed 80, indicating a strong bullish sentiment, though now approaching overbought territory.

The Moving Average Convergence Divergence (MACD) indicator has also flashed a positive crossover, confirming the upward momentum. These signals, along with significant volumes, suggest that the current rally is well-supported by market participants.

Ashish Kacholia’s Growing Stake Boosts Confidence

One of the key reasons driving optimism around Aeroflex Industries is the involvement of ace investor Ashish Kacholia, who is known for spotting multi-bagger small-cap stocks. According to March 2025 shareholding records, Kacholia raised his stake in the company to 1.92%, compared to 1.8% in December 2024.

Kacholia’s steady accumulation has boosted confidence among retail and institutional investors alike. His presence is often seen as an endorsement of a company’s future potential, especially within the small-cap space.

Strong Post-IPO Performance

Aeroflex Industries made its stock market debut in August 2023, with its IPO priced at ₹197 per share. On the listing day, the stock saw an impressive 83% premium, closing significantly higher than its issue price. Since its debut, the stock has roughly doubled, reflecting investor faith in the company’s growth trajectory.

Despite some periods of price consolidation, the stock has managed to retain market interest due to its solid business model and steady financial growth.

Financial Performance and Growth

In the fourth quarter of FY25, Aeroflex Industries posted a 16% year-on-year increase in revenue, totaling ₹92 crore. Net profit for the same period grew by 12% year-on-year to approximately ₹11 crore. Aeroflex Industries also posted a 21% rise in EBITDA, which reached ₹19 crore, with the EBITDA margin improving to 20.7%.

The company reported a solid full-year performance in FY25, with revenue rising by 18% and net profit growing by 26% to ₹53 crore. This steady financial growth has provided a strong foundation for the recent rally and justified investor optimism.

Operational Expansion and New Product Launches

Aeroflex Industries is not only growing financially but also expanding operationally. In January 2025, the company commenced the production of Metal Bellows, a specialized product used in various industrial applications. The annual production capacity for Metal Bellows is now pegged at 120,000 units.

Furthermore, the company has expanded its stainless-steel hose production capacity from 15 million meters to 16.5 million meters per year. Its composite hose manufacturing capability has also doubled from three lines to six lines, indicating the company’s readiness to meet growing market demand.

Valuation and Market Metrics

The company currently has an estimated market capitalization of approximately ₹2,700 crore. Its price-to-earnings (P/E) ratio ranges between 48x to 53x, which is relatively high, reflecting the market’s growth expectations. The price-to-book (P/B) ratio stands around 8.5x, and the stock has exhibited high volatility, with a beta close to 1.6.

While valuations appear stretched, the company’s growth trajectory, operational expansion, and high-profile investor backing seem to justify the premium at this stage.

Conclusion

The recent rally in Aeroflex Industries highlights a powerful combination of technical momentum, strong financial performance, and investor backing from seasoned market participants like Ashish Kacholia. The company’s proactive expansion efforts, new product offerings, and consistent earnings growth have further strengthened investor conviction.

As the stock continues to attract attention, particularly from value and momentum investors, Aeroflex Industries appears well-positioned to maintain its upward momentum in the near term. However, given the recent sharp rise, market participants may watch for potential consolidation before the next leg of the rally unfolds.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

B.R. Goyal Infra Shares Rise 7% After New Sewer Project Win

, , , , , , , , , 0 Comment
Read More
Healthcare Sector in India Set to Record 11% Rise in Revenue and EBITDA in Q1 FY26
Equities, Market News - June 21, 2025

B.R. Goyal Infra Shares Rise 7% After New Sewer Project Win

B.R. Goyal Infra Shares Rise 7% After New Sewer Project Win

New ₹64 Cr Sewer Project Boosts Order Book to ₹1,313 Cr, Fuels Investor Confidence in B.R. Goyal Infrastructure

Shares of B.R. Goyal Infrastructure Limited jumped by 7% following the company’s announcement that it had secured a ₹64 crore contract related to sewerage infrastructure development. Compared to its order book in September 2024, this marks a growth of approximately 56%, indicating strong project momentum and long-term revenue visibility.

The recently awarded contract falls under the urban sanitation category, an area the company is actively expanding into. This deal adds to B.R. Goyal Infra’s growing project portfolio, which now features *four new road development works, one major building construction project, eight toll operation contracts, and over ₹100 crore worth of wastewater management assignments. This diversification signals the firm’s commitment to expanding beyond traditional infrastructure into civic utilities and urban infrastructure.

In its latest financial report, the company showed a notable performance surge. Revenue grew by 39.5% on a quarter-on-quarter basis in the second half of FY25, and profits in the first half of the year nearly tripled compared to the previous reporting period. The company’s EBITDA margin improved to over 8%, while profit after tax (PAT) margin reached 4.96%, highlighting efficient operations and cost control.

B.R. Goyal Infrastructure continues to maintain a *low-debt business model, which has been a key strength in managing project risk. Additionally, it operates its own ready-mix concrete (RMC) facility in Indore and owns a fleet of more than *210 construction machines, giving it strong execution capability. With more than 900 employees and a presence across multiple Indian states, the company is well-positioned to execute and deliver on its growing number of contracts.

Analysts view this latest ₹64 crore contract as another step in the company’s ongoing shift into urban utility and sanitation infrastructure, complementing its strong presence in road construction and toll management. The news of this order appears to have boosted investor confidence, as reflected in the stock’s sharp rise on the trading day following the announcement.

Looking ahead, the company’s pipeline of diverse infrastructure projects, particularly in sanitation and wastewater, may serve as major growth drivers. With healthy profit margins, a lean balance sheet, and an expanding portfolio, B.R. Goyal Infrastructure is expected to benefit from India’s infrastructure push in the coming years.

Summary

The company continues to diversify into new areas like urban sanitation while maintaining strong financial performance, low debt, and operational efficiency—making it a growing force in the infrastructure space.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Bharti Airtel Stock Hits Fresh 52-Week High on Strong Market Momentum

, , , , , , , , , 0 Comment
Read More